DHR: Danaher Corporation - Summary | Jitta

Danaher Corporation

NYSE:DHR

Price
$252.73
Loss Chance
47.7%
5.16JITTA SCORE
90.04%Over Jitta Line
Jitta Ranking
537 / 1,128
3,496 / 4,928
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (30)
Recent Business Performance (18)
Financial Strength (87)
Return to Shareholders (37)
Competitive Advantage (39)
Jitta Signs
Revenue and EarningConsistent
Debt LevelLow Long Term Debt
Dividend PayoutEvery year
Interest Coverage RatioVery Good
SG&A to SalesDecreasing
Operating MarginDeclined
Recent Business PerformanceEarning decline 48.84% in the last quarter (yoy)
Key Stats
Jitta Score
Jitta Line
5.16
90.04%
2.06
245.44%
Life Sciences Tools and Services
4.14
> 1,000%
5.37
1.80%
6.39
10.94%
COMPANY DESCRIPTION
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins to academic and commercial research, agriculture, medical diagnostics, pharmaceutical development, biotechnology companies, clinical, and commercial applications. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians’ offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.